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Abstract
Iron modulates the expression of the critical citric acid cycle enzyme aconitase via a translational mechanism involving iron
regulatory proteins. Thus, the present study was undertaken to investigate the consequences of iron perturbation on citric
acid cycle activity, oxidative phosphorylation and mitochondrial respiration in the human cell line K-562. In agreement with
previous data iron increases the activity of mitochondrial aconitase while it is reduced upon addition of the iron chelator
desferrioxamine (DFO). Interestingly, iron also positively affects three other citric acid cycle enzymes, namely citrate
synthase, isocitric dehydrogenase, and succinate dehydrogenase, while DFO decreases the activity of these enzymes.
Consequently, iron supplementation results in increased formation of reducing equivalents (NADH) by the citric acid cycle,
and thus in increased mitochondrial oxygen consumption and ATP formation via oxidative phosphorylation as shown
herein. This in turn leads to downregulation of glucose utilization. In contrast, all these metabolic pathways are reduced
upon iron depletion, and thus glycolysis and lactate formation are significantly increased in order to compensate for the
decrease in ATP production via oxidative phosphorylation in the presence of DFO. Our results point to a complex
interaction between iron homeostasis, oxygen supply and cellular energy metabolism in human cells. ß 1999 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Glucose metabolism, the citric acid cycle (Krebs
cycle) and oxidative phosphorylation are central bio-
chemical pathways in cellular energy metabolism.
Glucose is taken up by secondary active transporter
proteins, and via glycolysis glucose is degraded to
pyruvate which is introduced into the citric acid cycle
after decarboxylation to acetyl coenzyme A. The
Krebs cycle provides NADH for oxidative phospho-
rylation to generate the electron gradient for ATP
formation [1].
Interestingly, evidence has been provided that the
citric acid cycle and iron homeostasis may be inter-
connected since iron perturbations modulate the ex-
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pression of the Krebs cycle enzyme mitochondrial
aconitase by a translational mechanism. This is ex-
erted by interaction of iron regulatory proteins (IRP)
with a RNA stem loop structure, iron responsive
elements (IRE), within the 5P untranslated region
(UTR) of mitochondrial aconitase mRNA [2^4]. Ac-
tivation of IRP-1 and IRP-2 binding to this IRE, as
occurs under iron deprivation states [5,6], oxidative
stress [7] or in the presence of nitric oxide [8,9], re-
sults in translational inhibition of mitochondrial aco-
nitase expression by preventing the binding of the
small ribosomal subunit to the mRNA [10]. By con-
trast, iron supplementation to cells decreases the IRE
binding a⁄nity of IRPs. While under such conditions
IRP-1 forms a central iron-sulfur cluster and acts as
a cytoplasmic aconitase [11^14], IRP-2 is degraded
[15^17], which in turn should increase aconitase
mRNA translation and expression.
Recently, evidence has been provided that another
citric acid cycle enzyme, succinate dehydrogenase
(SDH), may also be susceptible to iron-mediated reg-
ulation. At least in Drosophila melanogaster the sub-
unit b of SDH bears an IRE within its 5P UTR
[18,19] which causes regulation by iron in a similar
fashion as described for mitochondrial aconitase
[2,3].
To study the metabolic consequences of these in-
teractions between iron homeostasis and aconitase/
SDH on cellular energy metabolism we investigated
the e¡ects of iron perturbations on Krebs cycle en-
zyme activity, oxidative phosphorylation and mito-
chondrial oxygen consumption as well as glucose
metabolism.
2. Materials and methods
2.1. Materials
RPMI 1640 medium, fetal calf serum (FCS), pen-
icillin, streptomycin and L-glutamine were obtained
from Biochrom KG (Berlin, Germany). Pyruvate,
imidazole, glucose 6-phosphate, NAD, NADH,
NADH peroxidase, 6-phospho-gluconate dehydrog-
enase, LDH and diaphorase were purchased from
Boehringer-Mannheim GmbH (Germany). Iodoni-
trotetrazolium chloride was obtained from Boehr-
inger-Ingelheim (Heidelberg, Germany). The ATP
assay kit was provided by Calbiochem-Novabiochem
(California, USA). Assay kits for measurement of
LDH, lactate as well as the other reagents such as
desferrioxamine (DFO) and FeCl3 were from Sigma-
Aldrich (Munich, Germany).
2.1.1. Cell culture
All experiments were performed with K-562, a hu-
man erythroleukemic cell line [20]. Cells were cul-
tured in RPMI containing 10% (v/v) heat-inactivated
FCS, 2 mM L-glutamine, 100 U/ml penicillin, and
100 Wg/ml streptomycin. Cells were grown at 37‡C
in humidi¢ed air containing 5% CO2.
K-562 cells were induced for erythroid di¡erentia-
tion with 1.5 mM sodium butyrate for 24 h [21].
1.5U106 cells were then resuspended in 4 ml RPMI
containing 1.5 mM sodium butyrate and stimulated
with varying concentrations of FeCl3 or DFO for
24 h. Cells were harvested and washed twice with
5 ml ice-cold phosphate-bu¡ered saline (PBS) before
addition of 150 Wl distilled water to the cell pellet.
Cells were lysed by ¢ve cycles of freezing and thaw-
ing, and cell extracts were collected after centrifuga-
tion at 14 000Ug for 10 min. The protein concentra-
tion of the extracts was determined according to
Bradford [22].
2.2. Enzymatic assays and metabolite determination
2.2.1. Lactate dehydrogenase (LDH, EC 1.1.1.27)
Measurements of LDH activities in cell extracts
were performed as described in the manual of Sig-
ma-Aldrich (Munich, Germany).
2.2.2. Citrate synthase (EC 4.1.3.7) [23]
The reaction was started by pipetting 50 Wl cell
extract to 875 Wl reagent solution containing 0.1 M
Tris-HCl bu¡er, pH 8.1, 5 mM triethanolamine hy-
drochloride, 0.1 mM 5,5-dithio-bis-(2-nitrobenzoic)
acid ( = Ellman’s reagent), 0.5 mM oxaloacetate,
0.31 mM acetyl coenzyme A. The linear increase in
absorbance was measured at 412 nm.
2.2.3. Aconitase (EC 4.2.1.3) [24]
Cell extracts (60 Wl) were pipetted to 870 Wl solu-
tion containing 330 mM Tris-HCl, pH 7.4, 1.5 mM
manganese sulfate, 0.6 mM NADP, 1 U/ml isocitrate
dehydrogenase. The reaction was started by adding
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100 Wl of 20 mM sodium citrate solution, and the
increase in absorption was measured at 340 nm.
No changes in the relative e¡ects of iron and DFO
on aconitase activity were observed when comparing
aconitase activities in total cell extracts and extracts
treated with an anti-IRP antibody, which bound and
precipitated cytoplasmic aconitase (IRP-1, details not
shown).
2.2.4. Isocitrate dehydrogenase (EC 1.1.1.41) [25]
Enzyme activity was determined by a coupled as-
say. The reaction mixture contained 1.2 ml of 0.2 M
Tris-acetate bu¡er, pH 7.6, 50 Wl of 15 mM NAD,
50 Wl of 0.1 M MgCl2, 50 Wl of 25 mM DL-isocitric
acid, 40 Wl cell extract, 20 Wl of 20 mM AMP diso-
dium salt, and 10 Wl of 5.3 mM 2,6-dichlorophenol-
indophenol sodium salt. The reaction was started
upon addition of 0.5 U diaphorase (EC 1.8.1.4),
and the decrease in absorbance was recorded at
600 nm.
2.2.5. Succinate dehydrogenase (SDH, EC 1.3.99.1)
[26]
Cell extracts (50 Wl) were added to a cuvette with
950 Wl reagent solution containing 100 mM trietha-
nolamine hydrochloride, pH 8.3, 0.5 mM EDTA, 12
g/l Cremophor EL, 2 mM iodonitrotetrazolium
chloride, 2 mM potassium cyanide, 20 mM succinate.
The increase in absorbance at 500 nm was measured.
2.2.6. Glucose concentration
Deproteinized supernatant (50 Wl) was combined
with 950 Wl reagent solution (5 mM NaH2PO4, 375
mM Na2HPO4, 4 mM MgCl2, 0.771 mM NADP
sodium salt, 3.1 mM ATP disodium salt, pH 7.8).
The absorption E1 was measured at 365 nm. The
enzymatic reaction was then started upon addition
of 20 Wl enzyme solution (125 U/ml hexokinase,
75 U/ml glucose 6-phosphate dehydrogenase). E2
was determined thereafter, and glucose concentra-
tion (in mg/dl) was calculated as follows: vE =
(E23E1)U540.
2.2.7. NAD(H) concentration [27]
NADH peroxidase (NADH-POD) and glucose
6-phosphate dehydrogenase (G6PDH) were puri¢ed
using Sephadex G25 columns (Pharmacia-Biotech
AB, Uppsala, Sweden) rinsed with 0.1 M Tris-acetate
bu¡er, pH 8.5. Freshly prepared NADH standards
were dissolved in carbonate bu¡er (0.1 M Na2CO3,
0.1 M NaHCO3, pH 10.4). For measurement of
NAD levels 5 Wl of cell extracts were supplemented
with 995 Wl freshly prepared solution containing
50 mM H2SO4, 100 mM Na2SO4, 4 mM NaOH,
0.05 mM L-cysteine and 2.5 mM ascorbic acid. The
samples were heated at 60‡C for 30 min. For deter-
mination of NADH, 500 Wl carbonate solution (20
mM NaHCO3 and 100 mM Na2CO3) was added to
50 Wl cell extract and incubated at 60‡C for 10 min.
30 Wl of this sample and 150 Wl cycling reagent
(80 mM Tris, pH 8.5, 80 mM potassium acetate,
55 U/ml G6PDH, 4.5 U/ml NADH-POD, 2.4 mM
H2O2, 2.2 mM glucose 6-phosphate) were then incu-
bated at 30‡C for 2 h. After heat inactivation 1.5 ml
indicator solution, containing 20 mM Tris, pH 7.7,
30 mM ammonium acetate, 0.1 mM EDTA, 200 mg/l
bovine serum albumin (BSA), 0.03 mM NADP and
24 U/l 6-phosphogluconate dehydrogenase, was
added. The NAD/NADH content was recorded by
£uorescence determination at 339 nm excitation and
460 nm emission wavelength.
2.2.8. Lactate concentration
Deproteinized cell supernatant (33 Wl) was used for
determination of lactate by an assay kit obtained
from Sigma-Aldrich (Munich, Germany).
2.2.9. ATP concentration
ATP content in cell extracts was determined with
an assay kit of Calbiochem-Novabiochem (Califor-
nia, USA) using a chemoluminometer LUCY1 (An-
thos Labtec Instruments, Salzburg, Austria).
2.2.10. Mitochondrial DNA preparation [28]
Mitochondrial DNA was isolated by alkaline lysis
mini-preparation, visualized by 0.5% agarose gel
electrophoresis, and quanti¢ed spectrophotometri-
cally.
2.3. Measurement of mitochondrial oxygen
consumption
The determination of oxygen consumption was
performed with a two-channel titration-injection re-
spirometer at 37‡C (Oroboros Oxygraph, Innsbruck,
Austria) [29]. Cells were pelleted, washed with PBS,
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and then resuspended in prewarmed mitochondrial
medium [30] (0.5 mM EGTA, 3 mM MgCl2, 20
mM taurine, 10 mM KH2PO4, 20 mM HEPES,
200 mM sucrose and 1 g/l BSA, pH 7.1), and ad-
justed to a cell density of 1U106/ml. Endogenous
respiration of mitochondria can be converted to
ATP products by multiplication of oxygen consump-
tion and the P/O ratio [33]. After measurement of the
endogenous respiration cells were then permeabilized
with digitonin (¢nal concentration 4 Wg/106 cells),
and antimycin A (2.5 WM ¢nal concentration), the
arti¢cial electron donor TMPD (N,N,NP,NP-tetra-
methyl-p-phenylenediamine, ¢nal concentration 200
mM) and ascorbate (¢nal concentration 2 mM)
were added for determination of cytochrome c oxi-
dase (COX) activity. The total rates of oxygen con-
sumption were corrected for autoxidation of TMPD/
ascorbate by iron on separate experiments and the
corrections amounted to 6 15% of mitochondrial
respiration. The corrected rates of cellular oxygen
consumption were fully cyanide-sensitive [31].
3. Results
Since aconitase is subjected to iron-mediated reg-
ulation via IRE/IRP interactions, we ¢rst investi-
gated the e¡ects of iron perturbations on mitochon-
drial aconitase activity. In accordance with other
reports [2^4,11,12] treatment of cells with DFO
(200 WM) resulted in signi¢cant loss of aconitase ac-
tivity, whereas iron supplementation (200 WM)
caused an increase as compared to controls (Table
1). The e¡ect of 100 WM iron chloride could be re-
versed by addition of 200 WM DFO thus pointing to
the speci¢city of iron perturbations for aconitase reg-
ulation (details not shown). Importantly, treatment
with either the indicated dosages of iron or DFO did
not signi¢cantly a¡ect cell viability as checked by
trypan blue exclusion [34].
Interestingly, iron perturbations also slightly af-
fected the preceding and the consecutive steps of
the aconitase reaction. In a complementary fashion
to what we have observed for aconitase, treatment of
cells with iron increased both citrate synthase and
isocitrate dehydrogenase (IDH) activity, while cellu-
lar iron restriction upon addition of DFO resulted in
the opposite e¡ect as compared to controls (Table 1).
Similar to aconitase the e¡ect of iron on IDH activ-
ity could be abolished by DFO. Finally, we also in-
vestigated SDH since the mRNA of its isoform in
D. melanogaster bears an IRE and is thus susceptible
to iron-dependent regulation [18,19]. As is evident
from Table 1, iron supplementation enhances SDH
activity while iron deprivation reduces it as com-
pared to controls. Thus, iron supplementation stimu-
lated the activities of citric acid cycle enzymes while
iron depletion had the opposite e¡ect. To investigate
the possible impact of translational regulation on
both aconitase and SDH activities, cells were cul-
tured in the presence of cycloheximide, a known in-
hibitor of protein synthesis. This procedure led to a
more than 50% reduction of basic aconitase and
SDH activities, and combined treatment with DFO
and cycloheximide further decreased the enzymatic
activities of these proteins (Table 1). Mitochondrial
Table 1
E¡ects of iron perturbations on activity of Krebs cycle enzymes
200 WM DFO Control 100 WM FeCl3
Citrate synthase (mU/mg protein) n = 8 98.0 þ 8c 107.6 þ 10 110.4 þ 12c
Aconitase (mU/mg protein) n = 6 265.8 þ 21c 542.7 þ 105 727.9 þ 81a
Aconitase+40 WM cycloheximide (mU/mg protein) n = 14 153.4 þ 24c 250.6 þ 37 n.d.
Isocitrate dehydrogenase (U/mg protein) n = 19 2.18 þ 0.1b 2.43 þ 0.11 2.67 þ 0.1a
Succinate dehydrogenase (mU/mg protein) n = 6 1.20 þ 0.07c 1.37 þ 0.04 1.75 þ 0.12c
SDH+40 WM cycloheximide (mU/mg protein) n = 9 0.46 þ 0.05 0.52 þ 0.08 n. d.
Enzyme activities were determined in cell extracts after 24 h stimulation with 200 WM DFO or 100 WM iron chloride. Di¡erences com-
pared to controls were determined by paired Student’s t-test. Values are shown as means þ S.E.M. n.d. = not determined.
aP9 0.001.
bP9 0.01.
cP9 0.05.
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DNA was determined to have an estimation of the
number of mitochondria in cells. Treatment with
neither iron (100 WM) nor DFO (200 WM) obviously
altered the amount of mitochondrial DNA, which
indicates that the observed changes in enzyme activ-
ity following iron perturbation cannot relate to
varying numbers of mitochondria (details not
shown).
3.1. Iron perturbations modulate metabolites of energy
metabolism
Since IDH is centrally involved in the formation of
NADH [1], we next investigated whether alterations
of aconitase and IDH activity by iron may a¡ect
NADH production. As can be seen in Table 2, addi-
tion of DFO reduced NADH formation whereas iron
salts signi¢cantly increased the NADH content of
cells. No signi¢cant e¡ects were observed for changes
in the NAD content of cells upon iron perturbations,
which can be related to the fact that NAD levels are
an order of magnitude higher than cellular amounts
of NADH [27]. Finally, we calculated a ratio NAD/
NADH to have a better estimate of the relative avail-
ability of reduction equivalents showing that even
small concentrations of DFO (10 WM) signi¢cantly
increased the ratio (details not shown). Since NADH
is the major electron donor for oxidative phosphor-
ylation, we next investigated how the observed
changes in NADH levels may a¡ect the formation
of ATP by mitochondria. Our experiments demon-
strated that the increase in NADH levels in iron-
treated cells was paralleled by elevated cellular con-
centrations of ATP (Table 2).
Table 3
E¡ects of iron and DFO on glycolysis
200 WM DFO Control 100 WM FeCl3
Lactate dehydrogenase (U/mg protein) n = 14 14513 þ 2183a 11407 þ 1917 10127 þ 1518
Glucose (mmol/mg protein) n = 12 4.06 þ 0.34b 4.57 þ 0.3 4.91 þ 0.26a
Lactate (mmol/mg protein) n = 12 2.29 þ 0.12a 1.86 þ 0.12 1.8 þ 0.08
Concentrations of glucose and lactate were measured in supernatants of DFO- or iron-treated cell cultures after 24 h stimulation.
LDH activities were determined in cell extracts. Di¡erences compared to controls were determined by paired Student’s t-test. Values
are shown as means þ S.E.M.
aP9 0.001.
bP9 0.01.
Table 2
Iron-dependent changes in oxidative phosphorylation and mitochondrial respiration
200 WM DFO Control 200WM FeCl3
NADH (nmol/mg protein) n = 12 13.8 þ 1.3a 17.9 þ 1.4 21.7 þ 1.6c
NAD/NADH ratio n = 12 7.9 þ 0.9b 5.4 þ 0.5 5.1 þ 0.8
ATP (Wmol/mg protein) n = 12 41.3 þ 5.7 42.7 þ 5.6 57.5 þ 7.9c
Oxygen consumption (pM O2/s/106 cells) n = 5 200 WM DFO 100 WM FeCl3
Endogenous respiration 41.9 þ 2.3 56.9 þ 3.1a
COX activity 56.9 þ 1.8 70.5 þ 3.1b
Ratio COX/endogenous respiration 1.33 þ 0.03 1.24 þ 0.04c
NAD(H) and ATP concentrations were determined in cell extracts of iron-perturbed cells. Mitochondrial respiration was measured in
digitonin-permeabilized cells after stimulation with 200 WM DFO or 100 WM FeCl3 for 24 h. Di¡erences compared to controls were
determined by paired Student’s t-test. For estimating the signi¢cance of di¡erences in oxygen consumption DFO- and iron-treated
cells were compared by paired Students’s t-test. Values are shown as means þ S.E.M.
aP9 0.001.
bP9 0.01.
cP9 0.05.
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3.2. Iron increases oxygen consumption
To see whether these observations may a¡ect mi-
tochondrial respiration we investigated oxygen con-
sumption in cells treated with 200 WM DFO or
100 WM FeCl3 using an Oroboros oxygraph. Endog-
enous respiration of DFO-stimulated cells was 42 pM
O2/s/106 cells, whereas cells perturbed with iron con-
sumed 57 pM O2/s/106 cells. Most of the oxygen is
utilized by the respiratory chain, so that measure-
ment of oxygen consumption re£ects oxidative phos-
phorylation. This is true if the ratio between forma-
tion of ATP and oxygen consumption by the
respiratory chain (P/O ratio) is constant between
the experimental groups [32]. Assuming a maximal
P/O ratio of 2.5, oxidative ATP production was re-
duced in DFO-treated cells by not more than 0.7 nM
ATP/s/mg protein, whereas glycolytically produced
ATP was increased by 5 nM ATP/s/mg protein, as
calculated based on the accumulation of lactate (Ta-
ble 3) [33].
We then examined the possibility that iron pertur-
bations may a¡ect mitochondrial respiratory en-
zymes such as COX directly. COX activity in iron-
perturbed K-562 cells was 56.9 pM O2/s/106 cells
after treatment with DFO and 70.5 pM O2/s/106 cells
upon iron supplementation (Table 2). The ratio of
COX activity to endogenous respiration was 1.33 in
DFO-treated cells and 1.24 in iron-replenished ones
(Table 2). This indicates that in DFO-treated cells
endogenous respiration is more reduced by the
drug than speci¢c COX activity, demonstrating that
modulation of COX activity cannot primarily ac-
count for iron-mediated e¡ects on oxidative phos-
phorylation. Thus, mitochondrial respiration may
be rather in£uenced by iron and DFO-mediated
changes of citric acid cycle activity and NADH for-
mation.
3.3. Iron de¢ciency increases glucose utilization via
glycolysis
Cellular glucose utilization was estimated indi-
rectly by measuring glucose concentrations in super-
natants of iron-perturbed cells. We found an approx-
imately 10% higher glucose turnover in cells treated
with DFO (200 WM), while cells perturbed with iron
utilized 8.9% less glucose than controls (Table 3).
Accordingly, DFO-treated cells presented with high-
er lactate concentrations and LDH activities com-
pared to iron-treated cells (Table 3). Although all
these e¡ects were rather small they were highly re-
producible and caused signi¢cant di¡erences (Tables
1^3).
4. Discussion
Four enzymes of the tricarboxylic acid cycle
(Krebs cycle) were investigated in our study. First,
Fig. 1. Impact of iron perturbations on Krebs cycle activity,
oxidative phosphorylation and glycolysis. Iron deprivation upon
addition of DFO leads to reduced activities of citric acid cycle
enzymes (1), such as citrate synthase, aconitase, IDH and SDH,
which causes diminished formation of NADH (2). Furthermore,
low cellular NADH availability decreases mitochondrial ATP
formation and the oxygen consumption by the respiratory chain
(3). Low amounts of ATP formed by oxidative phosphorylation
lead to activation of phospho-fructokinase. This leads to stimu-
lation of glucose utilization and lactate accumulation (4) in or-
der to increase ATP formation by glycolysis (G). In contrast,
iron supplementation to cells results in the opposite e¡ects,
namely stimulation of enzymatic activities in citric acid cycle,
NADH formation and ATP production while glycolysis is re-
pressed.
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we demonstrated that aconitase activity decreased
upon DFO treatment. This is in accordance with
data showing that mitochondrial aconitase is regu-
lated translationally via IRE/IRP interactions [2^4]
but also posttranslationally by modulating the struc-
ture of a relatively unstable [4Fe-4S] cluster in the
enzyme’s active center [11^15]. DFO inactivates aco-
nitase by removing the labile iron atom from the
catalytic center of the enzyme’s iron-sulfur cluster
[11,12,35]. The existence of translational (IRP-medi-
ated) and posttranslational regulation of aconitase
activity by iron perturbations is in accordance with
our experimental data demonstrating that cyclohex-
imide reduces total aconitase activity but does not
fully abolish the regulatory e¡ect of DFO (Table 1).
Although citrate synthase is not regulated by the
IRP/IRE system we could show that iron perturba-
tions of cells can modulate this enzyme’s activity as
well. In vivo citrate synthase activity may be de-
creased either by altered enzyme expression and/or
further by citrate accumulation due to DFO-medi-
ated inhibition of aconitase, which may reduce cit-
rate synthase activity by product inhibition [1].
Just like citrate synthase IDH is not regulated by
the IRE/IRP system; however, its activity is altered
by iron perturbations. The reduction of aconitase
activity upon iron depletion should lead to decreased
formation of isocitrate, which is the substrate for
IDH. The limitation of the substrate could be a rea-
son for reduced IDH activity in iron-starved cells
although e¡ects of iron on IDH expression cannot
be ruled out since IDH activity has been reported to
be also regulated posttranslationally via phospho-
rylation [36].
As shown recently, the mRNA of SDH subunit b
of D. melanogaster contains a functional IRE, thus
causing translational regulation of SDH mRNA ex-
pression via IRP binding [2,18,19]. Moreover, in
analogy to aconitase the catalytic center of SDH
contains an iron-sulfur cluster [37]. Therefore, iron
perturbations may regulate SDH activity translation-
ally and posttranslationally as discussed above for
aconitase (Table 1). However, since an IRE has not
been detected so far in the untranslated region of
human SDH mRNA, it is questionable whether reg-
ulation of SDH expression as observed herein is con-
trolled by IRP-mediated mechanisms. Limited avail-
ability of succinyl coenzyme A, the substrate of
SDH, is not very likely to a¡ect SDH activity be-
cause 2-oxoglutarate and succinyl coenzyme A can
also be produced by other metabolic pathways (e.g.
amino acid degradation) apart from the citric acid
cycle [1].
The major task of the citric acid cycle is the for-
mation of reduction equivalents for oxidative phos-
phorylation. NADH and FADH are the major elec-
tron donors and thus, NADH levels provide insights
into the capacity of the citric acid cycle [1]. We have
shown herein that iron-depleted cells have reduced
activities of citrate synthase, aconitase, IDH and
SDH, which then results in decreased formation of
NADH. Thus, cells have an impaired ability to gen-
erate ATP by oxidative phosphorylation, which is
also re£ected by the ¢nding that mitochondrial oxy-
gen consumption is decreased during iron-deprived
states (Fig. 1, Table 2). Although there was a certain
e¡ect of iron and DFO on COX activity, it became
evident after the calculation of a COX/endogenous
respiration ratio that iron-mediated changes on en-
dogenous respiration are rather due to modulation of
citric acid cycle enzyme activities as described above.
In contrast, iron-replete cells had an optimized Krebs
cycle and a stimulated mitochondrial respiration as
re£ected by increased oxygen consumption and ATP
formation (Fig. 1).
Modulation of the Krebs cycle by iron also af-
fected glycolysis. This is partly due to the fact that
ATP exerts a negative feedback on the activity of
phospho-fructokinase, a central regulatory enzyme
of glycolysis [1,38]. Therefore, iron perturbations
not only increase cellular ATP content but at the
same time reduce glucose consumption. On the other
hand, iron deprivation resulted in reduced NADH
formation and subsequent ATP production. To over-
come this lack of oxidative ATP formation cells have
to intensify glycolysis to form NADH and ATP by
anaerobic mechanisms. Since in DFO-treated cells
the ATP content is reduced, phospho-fructokinase
activity should be increased and thus glucose break-
down by glycolysis may be stimulated [38]. As an
end-product pyruvate is formed, which is then enzy-
matically converted to lactate and NAD [1]. This
notion is supported by our results and by studies of
other groups showing increased lactate concentration
and LDH activities in iron-deprived cells [39] (Fig.
1). Thus, in iron-depleted cells anaerobic glycolysis is
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stimulated in order to overcome the decreased for-
mation of ATP by oxidative phosphorylation, which
is mainly due to downregulation of citric acid cycle
enzyme activities by DFO (Table 3, Fig. 1).
Iron not only a¡ects cellular oxygen consumption
but also in£uences the expression of the major oxy-
gen transporter, hemoglobin. This is due to the fact
that the key enzyme of heme biosynthesis, eALAS
(erythroid aminolevulinic acid synthase), is transla-
tionally regulated by iron via binding of IRPs to
an IRE within the 5P UTR of eALAS mRNA [40^
42]. Thus, high iron availability to cells not only
results in an optimized mitochondrial energy metab-
olism and increased oxygen consumption but also
leads to stimulation of heme biosynthesis and expan-
sion of the oxygen transport capacity of the organ-
ism. This tight regulation between iron supply and
oxygen is a favorable condition for proliferating cells
which need both oxygen and iron.
Moreover, a stimulated citric acid cycle leads to
the formation of citrate and ATP. Thus, iron by
itself could control its own intracellular supply not
only by the IRE/IRP system, but also by modulating
the intracellular concentration of its potential car-
riers, ATP and citrate [5,6]. Finally, limitation of
iron availability to cells, e.g. by diversion of cellular
iron tra⁄c as occurs under chronic in£ammatory
conditions thus leading to the so-called anemia of
chronic diseases [43,44], not only limits the availabil-
ity of this essential metal to invading microorganisms
and tumor cells. It also decreases their mitochondrial
respiration and the overall oxygen supply to them.
This may be a superior strategy of the body to con-
trol the proliferation of pathogens just by modulat-
ing the availability of a single molecule, namely iron.
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